CSL Reports US$2.6 Billion Net Loss Amid Restructuring and Lower US Flu Vaccination Rates

The company reported revenue of US$15.8 billion for 2025-26; however, one-off restructuring costs and impairments resulted in a net loss of US$2.6 billion.
by is licensed under
ad-image

Get latest news delivered daily!

We will send you breaking news right to your inbox

[ADD FORM IN PSYCODE "follow-us-card"]

Have a tip? Let us know!

ad-image
© 2026 structurefeeds.com, Privacy Policy